Antibodies against recombinant alpha-galactosidase A in Fabry disease: Subclass analysis and impact on response to treatment
van der Veen, S.J., van Kuilenburg, A.B.P., Hollak, C.E.M., Kaijen, P.H.P., Voorberg, J., Langeveld, M.
Published in Molecular genetics and metabolism (01.02.2019)
Published in Molecular genetics and metabolism (01.02.2019)
Get full text
Journal Article
206 ACE-INHIBITION REDUCES RADIATION PNEUMONITIS BY AMELIORATING ACUTE CARDIAC DAMAGE
van der Veen, S.J, Ghobadi, G, Bosman, G.W, Faber, H, Langendijk, J.A, Van Luijk, P, Coppes, R.P
Published in Radiotherapy and oncology (01.03.2012)
Published in Radiotherapy and oncology (01.03.2012)
Get full text
Journal Article
OC-0261: ACE-inhibition reduces acute cardiac damage to ameliorate radiation-induced lung dysfunction
van der Veen, S.J, Ghobadi, G, de Boer, R.A, Faber, H, Bosman, G.W, Brandenburg, S, Langendijk, J.A, van Luijk, P, Coppes, R.P
Published in Radiotherapy and oncology (01.03.2013)
Published in Radiotherapy and oncology (01.03.2013)
Get full text
Journal Article
Early start of enzyme replacement therapy in pediatric male patients with classical Fabry disease is associated with attenuated disease progression
van der Veen, S.J., Körver, S., Hirsch, A., Hollak, C.E.M., Wijburg, F.A., Brands, M.M., Tøndel, C., van Kuilenburg, A.B.P., Langeveld, M.
Published in Molecular genetics and metabolism (01.02.2022)
Published in Molecular genetics and metabolism (01.02.2022)
Get full text
Journal Article